CALCIMEDICA INC (CALC) Stock News

USA - NASDAQ:CALC - US38942Q2021 - Common Stock

3.34 USD

+0.13 (+4.05%)

Last: 11/12/2025, 8:00:02 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

CALC Latest News, Press Relases and Analysis

All

Press Releases

a day ago - By: CalciMedica, Inc.

CalciMedica Reports Third Quarter 2025 Financial Results and Provides Clinical & Corporate Updates

3 days ago - By: CalciMedica, Inc.

CalciMedica Presents Data from Preclinical Study of Auxora™ in an Animal Model of AKI at ASN Kidney Week 2025

a month ago - By: CalciMedica, Inc.

CalciMedica and Telperian Announce Collaboration to Integrate Innovative Artificial Intelligence Engine to Analysis of Clinical Trials of Auxora™

2 months ago - By: CalciMedica, Inc.

CalciMedica to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

8 months ago - By: CalciMedica, Inc.

CalciMedica Secures Credit Facility for Up to $32.5 Million

a year ago - By: Benzinga - Mentions: ZVIA AULT

Standard BioTools And 2 Other Penny Stocks Executives Are Buying

a year ago - By: BusinessInsider

News Image

CALC Stock Earnings: CalciMedica Beats EPS for Q2 2024

3 months ago - By: CalciMedica, Inc.

CalciMedica Reports Second Quarter 2025 Financial Results and Provides Clinical & Corporate Updates

3 months ago - By: Benzinga - Mentions: PBM ATEC EQ ZYXI ...

12 Health Care Stocks Moving In Friday's Intraday Session

4 months ago - By: CalciMedica, Inc.

CalciMedica to Participate in the H.C. Wainwright 4th Annual Kidney Virtual Conference

5 months ago - By: CalciMedica, Inc.

CalciMedica Announces Publication in the American Journal of Nephrology Discussing Design and Rationale of Phase 2 KOURAGE Trial of Auxora™ in AKI with Respiratory Failure

a year ago - By: InvestorPlace

CALC Stock Earnings: CalciMedica Beats EPS for Q2 2024

5 months ago - By: CalciMedica, Inc.

CalciMedica Announces Upcoming Symposium at the 43rd Vicenza Course AKI-CRRT-EBPT and Critical Care Nephrology Meeting

6 months ago - By: CalciMedica, Inc.

CalciMedica Reports First Quarter 2025 Financial Results and Provides Clinical & Corporate Updates

7 months ago - By: CalciMedica, Inc.

CalciMedica Announces Presentations at Upcoming Medical Meetings

8 months ago - By: CalciMedica, Inc.

CalciMedica Reports 2024 Financial Results and Provides Clinical & Corporate Updates

8 months ago - By: CalciMedica, Inc.

CalciMedica Presents AKI Data from a Post-Hoc Analysis of the Phase 2 CARDEA trial of Auxora™ in Severe COVID-19 Pneumonia at the 30th International AKI & CRRT Conference

9 months ago - By: CalciMedica, Inc.

CalciMedica Announces Upcoming Plenary Presentation at the 30th International AKI & CRRT Conference

9 months ago - By: CalciMedica, Inc.

CalciMedica to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference

10 months ago - By: CalciMedica, Inc.

CalciMedica Announces Appointment of Dr. Alan Glicklich to Board of Directors

a year ago - By: CalciMedica, Inc.

CalciMedica Announces Presentations at Upcoming Medical Meetings

a year ago - By: CalciMedica, Inc.

CalciMedica Reports Third Quarter 2024 Financial Results and Provides Clinical & Corporate Updates

a year ago - By: CalciMedica, Inc.

CalciMedica Announces Pricing of Public Offering of Common Stock

a year ago - By: CalciMedica, Inc.

CalciMedica Announces Proposed Public Offering of Common Stock

a year ago - By: CalciMedica, Inc.

CalciMedica to Present Late-Breaking Positive Data, Including a Win Ratio Analysis, from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP) at the American College of Gastroenterology (ACG) 2024 Annual Scientific Meeting

a year ago - By: CalciMedica, Inc.

CalciMedica to Host a Call to Review Full Data Set, including a Win Ratio Analysis, from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP)

a year ago - By: CalciMedica, Inc.

CalciMedica Announces Upcoming Late-Breaker Plenary Presentation at the American College of Gastroenterology (ACG) 2024 Annual Scientific Meeting

a year ago - By: CalciMedica, Inc.

CalciMedica to Present at the H.C. Wainwright 26th Annual Global Investment Conference

a year ago - By: CalciMedica, Inc.

CalciMedica Reports Second Quarter 2024 Financial Results and Provides Clinical & Corporate Updates